Author:
Deguchi Ichiro,Osada Takashi,Arai Noriko,Takahashi Shinichi
Publisher
Springer Science and Business Media LLC
Subject
Cardiology and Cardiovascular Medicine
Reference26 articles.
1. Inoue H, Fujiki A, Origasa H, Ogawa S, Okumura K, Kubota I, Aizawa Y, Yamashita T, Atarashi H, Horie M, Ohe T, Doi Y, Shimizu A, Chishaki A, Saikawa T, Yano K, Kitabatake A, Mitamura H, Kodama I, Kamakura S (2009) Prevalence of atrial fibrillation in the general population of Japan: an analysis based on periodic health examination. Int J Cardiol 137:102–107
2. Narita N, Okumura K, Kinjo T, Mikami J, Tsushima K, Takahashi R, Noro M, Hashimoto A, Sasaki T, Takaki M, Ishidoya E, Narita Y, Imai H, Ono E, Tomita H (2020) Trends in prevalence of non-valvular atrial fibrillation and anticoagulation therapy in a Japanese region—analysis using the National Health Insurance database. Circ J 84:706–713
3. Schnabel RB, Yin X, Gona P, Larson MG, Beiser AS, McManus DD, Cheh CN, Lubitz SA, Magnani JW, Ellinor PT, Seshadri S, Wolf PA, Vasan RS, Benjamin EJ, Levy D (2015) 50 year trends in atrial fibrillation prevalence, incidence, risk factors, and mortality in the Framingham Heart Study: a cohort study. Lancet 386:154–162
4. Kato Y, Hayashi T, Tanahashi N, Kobayashi S (2015) Japan Standard Stroke Registry Study Group. Cardioembolic stroke is the most serious problem in the aging society: Japan standard stroke registry study. J Stroke Cerebrovasc Dis 24:811–814
5. Ono K, Iwasaki Y, Shimizu W (2021) JCS/JHRS 2020 Guideline on pharmacotherapy of cardiac arrhythmias. The Japanese Circulation Society/Japanese Heart Rhythm Society Joint Guidelines. Available at: http://www.j-circ.or.jp/guideline/pdf/JCS2020_Ono.pdf Accessed 28 Mar 2021 [In Japanese]